Delanzomib

An orally bioavailable synthetic P2 threonine boronic acid inhibitor of the chymotrypsin-like activity of the proteasome, with potential antineoplastic activity. Delanzomib represses the proteasomal degradation of a variety of proteins, including inhibitory kappaBalpha (IkappaBalpha), resulting in the cytoplasmic sequestration of the transcription factor NF-kappaB; inhibition of NF-kappaB nuclear translocation and transcriptional up-regulation of a variety of cell growth-promoting factors; and apoptotic cell death in susceptible tumor cell populations. In vitro studies indicate that this agent exhibits a favorable cytotoxicity profile toward normal human epithelial cells, bone marrow progenitors, and bone marrow-derived stromal cells relative to the proteasome inhibitor bortezomib. The intracellular protein IkappaBalpha functions as a primary inhibitor of the proinflammatory transcription factor NF-kappaB. (NCI Thesaurus)

YOU MAY ALSO LIKE

Delamination

Issue associated with peeling of composite materials. Occurs when layers are separated as a result of continuous stress or impact. Results in…

DEK/NUP214 Fusion Protein

A fusion protein encoded by the DEK/NUP214 fusion gene. This protein is comprised of the majority of protein DEK followed by 2/3…

DEK/NUP214 Fusion Gene

A fusion gene that results from a chromosomal translocation t(6;9)(p23;q34) which fuses almost the entire DEK gene with the 5' side of…

DEK wt Allele

Human DEK wild-type allele is located within 6p23 and is approximately 40 kb in length. This allele, which encodes protein DEK, plays…

DEK Gene

This gene is involved in RNA processing and regulation of chromatin organization.

Deionizer Device Component

A device designed to remove ions from a substance or environment.